[INHIBITION OF MITOCHONDRIAL MONOAMINE OXIDASE BY 3,4-DIMETHOXYBENZYL HYDRAZINE (VETRAZINE) AND RELATED COMPOUNDS]. 1964

I V VEREVKINA, and V Z GORKIN, and A N KOST, and R S SAGITULLIN

UI MeSH Term Description Entries
D008763 Methylhydrazines Hydrazines substituted by one or more methyl groups in any position.
D008928 Mitochondria Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed) Mitochondrial Contraction,Mitochondrion,Contraction, Mitochondrial,Contractions, Mitochondrial,Mitochondrial Contractions
D008995 Monoamine Oxidase An enzyme that catalyzes the oxidative deamination of naturally occurring monoamines. It is a flavin-containing enzyme that is localized in mitochondrial membranes, whether in nerve terminals, the liver, or other organs. Monoamine oxidase is important in regulating the metabolic degradation of catecholamines and serotonin in neural or target tissues. Hepatic monoamine oxidase has a crucial defensive role in inactivating circulating monoamines or those, such as tyramine, that originate in the gut and are absorbed into the portal circulation. (From Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 8th ed, p415) EC 1.4.3.4. Amine Oxidase (Flavin-Containing),MAO,MAO-A,MAO-B,Monoamine Oxidase A,Monoamine Oxidase B,Type A Monoamine Oxidase,Type B Monoamine Oxidase,Tyramine Oxidase,MAO A,MAO B,Oxidase, Monoamine,Oxidase, Tyramine
D008996 Monoamine Oxidase Inhibitors A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) MAO Inhibitor,MAO Inhibitors,Reversible Inhibitors of Monoamine Oxidase,Monoamine Oxidase Inhibitor,RIMA (Reversible Inhibitor of Monoamine Oxidase A),Reversible Inhibitor of Monoamine Oxidase,Inhibitor, MAO,Inhibitor, Monoamine Oxidase,Inhibitors, MAO,Inhibitors, Monoamine Oxidase
D012106 Research Critical and exhaustive investigation or experimentation, having for its aim the discovery of new facts and their correct interpretation, the revision of accepted conclusions, theories, or laws in the light of newly discovered facts, or the practical application of such new or revised conclusions, theories, or laws. (Webster, 3d ed) Research Priorities,Laboratory Research,Research Activities,Research and Development,Activities, Research,Activity, Research,Development and Research,Priorities, Research,Priority, Research,Research Activity,Research Priority,Research, Laboratory
D006834 Hydrazines Substituted derivatives of hydrazine (formula H2N-NH2). Hydrazide
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

I V VEREVKINA, and V Z GORKIN, and A N KOST, and R S SAGITULLIN
September 1976, Biochemical pharmacology,
I V VEREVKINA, and V Z GORKIN, and A N KOST, and R S SAGITULLIN
August 1986, Journal of neurochemistry,
I V VEREVKINA, and V Z GORKIN, and A N KOST, and R S SAGITULLIN
November 1995, Bioorganic & medicinal chemistry,
I V VEREVKINA, and V Z GORKIN, and A N KOST, and R S SAGITULLIN
April 1973, Nature,
I V VEREVKINA, and V Z GORKIN, and A N KOST, and R S SAGITULLIN
June 1976, Neuropharmacology,
I V VEREVKINA, and V Z GORKIN, and A N KOST, and R S SAGITULLIN
October 1984, Naunyn-Schmiedeberg's archives of pharmacology,
I V VEREVKINA, and V Z GORKIN, and A N KOST, and R S SAGITULLIN
April 1988, Journal of neurochemistry,
I V VEREVKINA, and V Z GORKIN, and A N KOST, and R S SAGITULLIN
January 1981, General pharmacology,
I V VEREVKINA, and V Z GORKIN, and A N KOST, and R S SAGITULLIN
January 1969, Chemical & pharmaceutical bulletin,
I V VEREVKINA, and V Z GORKIN, and A N KOST, and R S SAGITULLIN
March 2020, Chemical biology & drug design,
Copied contents to your clipboard!